Internal Medicine
| 2 min read
Qureight’s Vascul8 model uses AI to analyse CT scans and identify patients at risk of residual pulmonary hypertension after surgery.
| 4 min read
Scientists are using insights from viral hijacking to chemically reprogram E3 ligases, opening new opportunities in drug discovery.
| 3 min read
A team from Stanford and NYU shows how Bacteroides fragilis can activate pain pathways, revealing a new microbial culprit in digestive disease.
| 3 min read
A novel cannabis-based therapy shows promise as a safe, effective non-opioid alternative for chronic low back pain.
| 7 min read
Men have long lacked reversible contraceptives, but new hormonal and non-hormonal methods in development could finally give them control over family planning.
| 5 min read
Animal and cell culture models have fallen short in kidney disease research. Kidney organoids may offer a better way forward.
| 2 min read
A $500k award will support a two-phase study enrolling pregnant women to advance understanding of placental dysfunction.
| 2 min read
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists via BioMed X’s global talent sourcing and incubation model.
| 2 min read
First DPP1 inhibitor drug milestone marks a long-awaited breakthrough for NCFB patients.
| 4 min read
For rare and inherited kidney diseases, genetic testing is solving the clinical trial recruitment crisis and reshaping how precision therapies get to patients.
| 2 min read
The new DMF gives developers a faster, simpler path to advance their cell therapy programs using trusted, clinical-grade starting materials.
| 3 min read
Insilico’s Phase 2a trial of an AI-designed therapy marks a milestone in data-driven drug development.
